These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20811055)

  • 1. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
    Shih MH; Huang FC
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
    Moshirfar M; Meyer JJ; Espandar L
    J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
    Hu FR; Luh KT
    Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
    Stevens RK; Holland GN; Paschal JF; Phinney RB; Berlin OG; Bruckner DA
    Cornea; 1992 Nov; 11(6):500-4. PubMed ID: 1468211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
    Sarayba MA; Shamie N; Reiser BJ; Sweet PM; Taban M; Graff JM; Kesler-Diaz A; Osann KE; McDonnell PJ
    J Cataract Refract Surg; 2005 Jul; 31(7):1396-402. PubMed ID: 16105613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increasing problem of antibiotic resistance.
    Mamalis N
    J Cataract Refract Surg; 2007 Nov; 33(11):1831-2. PubMed ID: 17964369
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
    Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
    Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
    Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
    J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits.
    Oksuz H; Duran N; Tamer C; Cetin M; Silici S
    Ophthalmic Res; 2005; 37(6):328-34. PubMed ID: 16138004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
    Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR
    Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R; Cockrum P; Crider J; Schlech B
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
    Helm CJ; Holland GN; Lin R; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1993 Dec; 116(6):700-7. PubMed ID: 8250072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
    Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
    Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination drug testing of Mycobacterium chelonae.
    Matoba AY; Lee BL; Robinson NM; Penland R; Osato MS
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2786-9. PubMed ID: 8344799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.